675 related articles for article (PubMed ID: 25822684)
41. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
Stein HJ; Kauer WK; Feussner H; Siewert JR
J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
[TBL] [Abstract][Full Text] [Related]
42. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
[TBL] [Abstract][Full Text] [Related]
43. Chemoprevention in Barrett's esophagus: A pill a day?
Jankowski JA; Hooper PA
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):155-70. PubMed ID: 21112505
[TBL] [Abstract][Full Text] [Related]
44. Reflux disease and Barrett's esophagus.
Koop H
Endoscopy; 2000 Feb; 32(2):101-7. PubMed ID: 10696837
[TBL] [Abstract][Full Text] [Related]
45. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery?
Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ
Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570
[TBL] [Abstract][Full Text] [Related]
46. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Kumagai H; Mukaisho K; Sugihara H; Miwa K; Yamamoto G; Hattori T
Carcinogenesis; 2004 May; 25(5):723-7. PubMed ID: 14754873
[TBL] [Abstract][Full Text] [Related]
47. Animal Model: Reflux Models in Esophageal Adenocarcinoma.
Masuda T; Mittal SK
Methods Mol Biol; 2018; 1756():143-150. PubMed ID: 29600367
[TBL] [Abstract][Full Text] [Related]
48. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
49. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.
Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H
Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117
[TBL] [Abstract][Full Text] [Related]
50. Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Neoplasia.
Fedorova E; Watson TJ
Surg Clin North Am; 2021 Jun; 101(3):391-403. PubMed ID: 34048760
[TBL] [Abstract][Full Text] [Related]
51. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
52. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management.
Stein HJ; Siewert JR
Dysphagia; 1993; 8(3):276-88. PubMed ID: 8359051
[TBL] [Abstract][Full Text] [Related]
53. Acid suppression and surgical therapy for Barrett's oesophagus.
de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462
[TBL] [Abstract][Full Text] [Related]
54. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.
Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M
Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363
[TBL] [Abstract][Full Text] [Related]
55. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
56. Barrett's esophagus.
Attwood SE
Curr Opin Gen Surg; 1993; ():180-8. PubMed ID: 7583962
[TBL] [Abstract][Full Text] [Related]
57. Bile acids but not acidic acids induce Barrett's esophagus.
Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
[TBL] [Abstract][Full Text] [Related]
58. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
Morgan G
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
[No Abstract] [Full Text] [Related]
59. [Barrett's esophagus and primary adenocarcinoma of the esophagus].
Seco JL; Velasco A; Hilario E; Corrales JI; Alvarez JL; Ojeda C; SantamarÃa JL
Rev Esp Enferm Apar Dig; 1981 May; 59(5):617-26. PubMed ID: 7291673
[No Abstract] [Full Text] [Related]
60. Management of the patient with Barrett's esophagus: a continuing dilemma for the clinician.
Katz PO
Rev Gastroenterol Disord; 2004; 4(2):49-59. PubMed ID: 15184824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
